These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment. Shoda H, Inokuma S, Yajima N, Tanaka Y, Setoguchi K. Ann Rheum Dis; 2005 Apr; 64(4):651-2. PubMed ID: 15769928 [No Abstract] [Full Text] [Related]
3. Atypical Painful Purpuric Cutaneous Nodules With Ibrutinib. Marcaillou M, Stéphanie D, Marion B, Julien S, Christophe B. Am J Dermatopathol; 2020 Dec; 42(12):1012-1014. PubMed ID: 32675466 [No Abstract] [Full Text] [Related]
14. [Hypersensitivity reactions to cancer chemotherapeutic agents]. Sato A, Sakashita A, Taguchi S. Gan To Kagaku Ryoho; 2003 Jun; 30(6):793-800. PubMed ID: 12852346 [Abstract] [Full Text] [Related]
16. Rituximab-induced vasculitis: A case report and review of the medical published work. Kim MJ, Kim HO, Kim HY, Park YM. J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999 [Abstract] [Full Text] [Related]
17. Methotrexate related cutaneous vasculitis. Torner O, Ruber C, Olive A, Tena X. Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315 [No Abstract] [Full Text] [Related]
19. Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy. Niscola P, Del Principe MI, Maurillo L, Venditti A, Buccisano F, Piccioni D, Amadori S, Del Poeta G. Leukemia; 2005 Oct; 19(10):1840-1. PubMed ID: 16094417 [No Abstract] [Full Text] [Related]
20. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Rigamonti C, Volta C, Colombi S, Forti L, Savinelli F, Gaidano G, Bartoli E. Leukemia; 2001 Jan; 15(1):186-7. PubMed ID: 11243389 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]